Table 1.
Clinical characteristics of the subjects who participated in the study
| Sample | Parameter | HC | Non-PPI-user | PPI user | P value |
|---|---|---|---|---|---|
| Gastric | No. of subjects | 5 | 10 | 20 | |
| PPI therapy duration (months) | – | – | 13 (3–120) | – | |
| Age (mean ± SD) | 47.4 ± 7 | 54.2 ± 11 | 49.05 ± 13.3 | 0.469 | |
| Sex (male/female) | 3/2 | 6/4 | 9/11 | 0.679 | |
| BMI (kg/m2) | 24.6 ± 4 | 27.3 ± 7 | 24.9 ± 6.2 | 0.574 | |
| Fecal | No. of subjects | 15 | 15 | 25 | |
| PPI therapy duration (months) | – | – | 16 (2–120) | ||
| Age (mean ± SD) | 45.5 ± 10 | 52.6 ± 13 | 46.9 ± 10.8 | 0.184 | |
| Sex (male/female) | 7/8 | 9/6 | 12/13 | 0.628 | |
| BMI (kg/m2) | 23.8 ± 6 | 26.6 ± 8 | 25.0 ± 5.3 | 0.480 | |